Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies

被引:53
作者
Bishop, F. L. [1 ]
Rea, A.
Lewith, H.
Chan, Y. K.
Saville, J.
Prescott, P. [2 ]
von Elm, E. [3 ,4 ]
Lewith, G. T.
机构
[1] Univ Southampton, Dept Primary Med Care, Aldermoor Hlth Ctr, Sch Med, Southampton SO16 5ST, Hants, England
[2] Univ Southampton, Sch Math, Southampton SO16 5ST, Hants, England
[3] Univ Med Ctr Freiburg, German Cochrane Ctr, Freiburg, Germany
[4] Swiss Parapleg Res, Nottwil, Switzerland
关键词
alternative therapies; complementary therapies; prostatic neoplasms; review; surveys; ALTERNATIVE MEDICINE; PC-SPES; STANDARD HISTORY; HERBAL THERAPY; SUPPLEMENT USE; HEALTH; PREVENTION; SURVIVORS; PATTERNS; BREAST;
D O I
10.1038/pcan.2010.38
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Men with prostate cancer are reported as commonly using complementary and alternative medicine (CAM) but surveys have not recently been subjected to a rigorous systematic review incorporating quality assessment. Six electronic databases were searched using pre-defined terms. Detailed information was extracted systematically from each relevant article. Study reporting quality was assessed using a quality assessment tool, which demonstrated acceptable inter-rater reliability and produces a percentage score. In all, 42 studies are reviewed. All were published in English between 1999 and 2009; 60% were conducted in the United States. The reporting quality was mixed (median score = 66%, range 23-94%). Significant heterogeneity precluded formal meta-analysis. In all, 39 studies covering 11 736 men reported overall prevalence of CAM use; this ranged from 8 to 90% (median = 30%). In all, 10 studies reported prevalence of CAM use specifically for cancer care; this ranged from 8 to 50% (median = 30%). Some evidence suggested CAM use is more common in men with higher education/incomes and more severe disease. The prevalence of CAM use among men with prostate cancer varies greatly across studies. Future studies should use standardised and validated data collection techniques to reduce bias and enhance comparability. Prostate Cancer and Prostatic Diseases (2011) 14, 1-13; doi: 10.1038/pcan.2010.38; published online 19 October 2010
引用
收藏
页码:1 / 13
页数:13
相关论文
共 77 条
[71]   The use of complementary therapy by men with prostate cancer in the UK [J].
Wilkinson, S. ;
Farrelly, S. ;
Low, J. ;
Chakraborty, A. ;
Williams, R. ;
Wilkinson, S. .
EUROPEAN JOURNAL OF CANCER CARE, 2008, 17 (05) :492-499
[72]   Attitudes and use of complementary medicine in men with prostate cancer [J].
Wilkinson, S ;
Gomella, LG ;
Smith, JA ;
Brawer, MK ;
Dawson, NA ;
Wajsman, Z ;
Dai, LT ;
Chodak, GW .
JOURNAL OF UROLOGY, 2002, 168 (06) :2505-2509
[73]   Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer [J].
Wilt, Timothy J. ;
MacDonald, Roderick ;
Rutks, Indulis ;
Shamilyan, Tatyana A. ;
Taylor, Brent C. ;
Kane, Robert L. .
ANNALS OF INTERNAL MEDICINE, 2008, 148 (06) :435-448
[74]   Supplement use among men with prostate cancer [J].
Wiygul, JB ;
Evans, BR ;
Peterson, BL ;
Polascik, TJ ;
Walther, PJ ;
Robertson, CN ;
Albala, DM ;
Demark-Wahnefried, W .
UROLOGY, 2005, 66 (01) :161-166
[75]   Complementary therapy use among older cancer patients [J].
Wyatt, GK ;
Friedman, LL ;
Given, CW ;
Given, BA ;
Christensen, K .
CANCER PRACTICE, 1999, 7 (03) :136-144
[76]   Use of complementary and alternative medicine by patients with urologic cancer: a prospective study at a single Japanese institution [J].
Yoshimura, K ;
Ueda, N ;
Ichioka, K ;
Matsui, Y ;
Terai, A ;
Arai, Y .
SUPPORTIVE CARE IN CANCER, 2005, 13 (09) :685-690
[77]   Use of complementary and alternative medicine by patients with localized prostate carcinoma: Study at a single institute in Japan [J].
K. Yoshimura ;
K. Ichioka ;
N. Terada ;
A. Terai ;
Y. Arai .
International Journal of Clinical Oncology, 2003, 8 (1) :26-30